22 Hrs
Source:
هبة بريس
Scientists near cancer defeat with new vaccines
Moderna and Merck have successfully completed the third phase of trials for a personalized treatment for melanoma skin cancer. This treatment is custom-made for each patient based on the genetic profile of their tumor. It is administered after surgery and represents a significant step toward producing tailored vaccines for individual patients—not a universal vaccine that prevents all types of cancer. Positive results suggest that the medical use of this individualized therapy is nearing reality.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)